BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 29020042)

  • 1. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.
    Coulibaly YI; Coulibaly SY; Dolo H; Konate S; Diallo AA; Doumbia SS; Soumaoro L; Coulibaly ME; Dicko I; Sangare MB; Dembele B; Sangare M; Dembele M; Touré YT; Kelly-Hope L; Polman K; Kyelem D; Traore SF; Bockarie M; Klion AD; Nutman TB
    Parasit Vectors; 2016 Dec; 9(1):628. PubMed ID: 27912789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
    Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
    PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission.
    Dorkenoo MA; de Souza DK; Apetogbo Y; Oboussoumi K; Yehadji D; Tchalim M; Etassoli S; Koudou B; Ketoh GK; Sodahlon Y; Bockarie MJ; Boakye DA
    Parasit Vectors; 2018 Jan; 11(1):52. PubMed ID: 29361964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis transmission on Mafia Islands, Tanzania: Evidence from xenomonitoring in mosquito vectors.
    Derua YA; Rumisha SF; Batengana BM; Max DA; Stanley G; Kisinza WN; Mboera LEG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005938. PubMed ID: 28985217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing a method of sampling for entomological determination of transmission of Wuchereria bancrofti to inform lymphatic filariasis treatment strategy in urban settings.
    Nditanchou R; Dixon R; Pam D; Isiyaku S; Nwosu C; Sanda S; Schmidt E; Koudou B; Molyneux D
    Parasit Vectors; 2020 Jan; 13(1):37. PubMed ID: 31973747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
    Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea.
    Kouassi BL; de Souza DK; Goepogui A; Narh CA; King SA; Mamadou BS; Diakité L; Dadzie SK; Boakye DA; Utzinger J; Bockarie MJ; Koudou BG
    Parasit Vectors; 2015 Sep; 8():492. PubMed ID: 26410739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza E; Gasarasi DB; Minzi OM
    Infect Dis Poverty; 2021 Mar; 10(1):20. PubMed ID: 33648600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
    de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
    Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis baseline survey in two sentinel sites of Ogun state, Nigeria.
    Okorie PN; Davies E; Ogunmola OO; Ojurongbe O; Saka Y; Okoeguale B; Braide EI
    Pan Afr Med J; 2015; 20():397. PubMed ID: 26185587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.
    Khan AM; Dutta P; Sarmah CK; Baruah NK; Das S; Pathak AK; Sarmah P; Hussain ME; Mahanta J
    J Vector Borne Dis; 2015 Dec; 52(4):314-20. PubMed ID: 26714512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil.
    Ramesh A; Cameron M; Spence K; Hoek Spaans R; Melo-Santos MAV; Paiva MHS; Guedes DRD; Barbosa RMR; Oliveira CMF; Sá A; Jeffries CL; Castanha PMS; Oliveira PAS; Walker T; Alexander N; Braga C
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006816. PubMed ID: 30325933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.